TFA
STOK icon

Toth Financial Advisory’s Stoke Therapeutics STOK Stock Holding History

Toth Financial Advisory’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-60
Closed -$2K – 791
2021
Q2 		$2K Hold
60
– – ﹤0.01% 613
2021
Q1 		$2K Hold
60
– – ﹤0.01% 612
2020
Q4 		$4K Hold
60
– – ﹤0.01% 481
2020
Q3 		$2K Hold
60
– – ﹤0.01% 495
2020
Q2 		$1K Hold
60
– – ﹤0.01% 521
2020
Q1 		$1K Buy
+60
New +$1.48K ﹤0.01% 434

Other funds holding STOK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Toth Financial Advisory's STOK Position: Q3 2021 in Review

Toth Financial Advisory sold out of Stoke Therapeutics (STOK) in Q3 2021, closing a stake of 60 shares — an estimated $2K sold.

Toth Financial Advisory first reported a position in STOK in Q1 2020 and held it in 6 quarters. The position peaked at $4K in Q4 2020. 90 funds tracked by Wall St. Rank hold STOK as of Q3 2021.

  • Toth Financial Advisory reported no remaining Stoke Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Toth Financial Advisory sold 60 Stoke Therapeutics shares in Q3 2021, an estimated $2K.
  • Toth Financial Advisory first reported a position in Stoke Therapeutics in Q1 2020 and held it in 6 quarters.
  • Toth Financial Advisory's Stoke Therapeutics position peaked at $4K in Q4 2020.
  • 90 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q3 2021.

Based on Toth Financial Advisory's 13F filing for Q3 2021, filed 20 Oct 2021.